Defining "elderly" in clinical practice guidelines for pharmacotherapy

Abstract

Objective:To identify how ‘elderly’ patients are defined and considered within Australian clinical guidelines for the use of pharmacotherapy.Method:Guidelines pertaining to the use of pharmacotherapy, focusing on conditions described in National Health Priority Areas, were identified using databases (Medline, Google Scholar) and organisation websites (Department of Health and Ageing, National Heart Foundation, National Health and Medical Research Council). Guidelines were reviewed and qualitatively analysed to identify any references or definitions of ‘elderly’ persons.Results:Among the 20 guidelines reviewed, 3 defined ‘elderly’ by chronological age (i.e., years since birth) while the remaining 17 guidelines did not define ‘elderly’ in any way. All 20 guidelines used the term ‘elderly’, whilst some guidelines provided age (chronological)-based dosage recommendations suggesting an ageist or generalist approach in their representation of ‘elderly’, for which rationale was seldom provided. Thematic analysis of the statements revealed five key themes regarding how ‘elderly’ was considered within the guidelines, broadly describing ‘elderly’ persons as being frail and with altered pharmacology. Some guidelines also highlighted the limited evidence base to direct clinical decision-making. A continuum of perceptions of ageing also emerged out of the identified themes.Conclusion:Clinical practice guidelines currently do not adequately define ‘elderly’ persons and provide limited guidance on how to apply treatment recommendations to older persons. The representation of ‘elderly’ in guidelines needs to be less based on chronological age or generic definitions focusing more on establishing a direct link between an individual patient’s characteristics and the pharmacology of their prescribed medication. Clinical guidelines that do not offer any practical descriptions of the features of ageing that are specifically related to the use of pharmacotherapy, or how to assess these in individual patients, render decision-making challenging.

Prevalence of Sarcopenia Adjusted Body Mass Index in the Korean Woman Based on the Korean National Health and Nutritional Examination Surveys

“…The status of society is divided into three categories based on proportion of population of 65 years and over: Ageing society (7%-14% elderly population), aged society (14%-20%), super-aged society (exceed 20%). [910]…”

Hepatitis C Infection in the Elderly

“…The definition of what constitutes the ''elderly'' is arbitrary and varies [4,5]. The commonly used age threshold of 65 years of age stems from the designation utilized by the pension program in Germany in the late nineteenth century [6].…”

Pharmacotherapy in the ageing patient: The impact of age per se (A review)

“…Clinicians may be reluctant to prescribe medications in the absence of evidence of safety and efficacy in the older population. Likewise, the use of chronological age to guide recommendations within clinical guidelines may also lead to inappropriate medication use, since these recommendations are generalised in a patient population beyond a certain age (Singh and Bajorek, 2014). Such guidelines overlook the divergence that exists in the health status (e.g.…”

“…In a cross-sectional study of 703 general practitioners, Lugtenberg et al (2011) identified that a lack of applicability of the recommendations presented in clinical guidelines was an important barrier to guideline adherence. Recently, in a study of 20 Australian clinical guidelines, it was found that most of these guidelines presented no definition for the term 'elderly', while some used only chronological age-based definitions (Singh and Bajorek, 2014). Clinical guidelines also failed to establish a relationship between an individual patient's physical status and the pharmacology of recommended medications.…”